日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A human antibody derived from original SARS-CoV-2 infection effectively neutralizes omicron

源自原始SARS-CoV-2感染的人类抗体可有效中和omicron

Li, Tingting; Zhou, Bingjie; Dong, Haoyu; Lavillette, Dimitri; Li, Dianfan

Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection

作者更正:一种靶向RBD的合成纳米抗体可保护仓鼠免受SARS-CoV-2感染。

Li, Tingting; Cai, Hongmin; Yao, Hebang; Zhou, Bingjie; Zhang, Ning; van Vlissingen, Martje Fentener; Kuiken, Thijs; Han, Wenyu; GeurtsvanKessel, Corine H; Gong, Yuhuan; Zhao, Yapei; Shen, Quan; Qin, Wenming; Tian, Xiao-Xu; Peng, Chao; Lai, Yanling; Wang, Yanxing; Hutter, Cedric A J; Kuo, Shu-Ming; Bao, Juan; Liu, Caixuan; Wang, Yifan; Richard, Audrey S; Raoul, Hervé; Lan, Jiaming; Seeger, Markus A; Cong, Yao; Rockx, Barry; Wong, Gary; Bi, Yuhai; Lavillette, Dimitri; Li, Dianfan

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

更正:新型高效靶向DHODH的抑制剂是广谱抗病毒药物,可对抗包括新出现的冠状病毒SARS-CoV-2在内的多种RNA病毒。

Xiong, Rui; Zhang, Leike; Li, Shiliang; Sun, Yuan; Ding, Minyi; Wang, Yong; Zhao, Yongliang; Wu, Yan; Shang, Weijuan; Jiang, Xiaming; Shan, Jiwei; Shen, Zihao; Tong, Yi; Xu, Liuxin; Chen, Yu; Liu, Yingle; Zou, Gang; Lavillette, Dimitri; Zhao, Zhenjiang; Wang, Rui; Zhu, Lili; Xiao, Gengfu; Lan, Ke; Li, Honglin; Xu, Ke

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant

原型疫苗和 Omicron RBD mRNA 疫苗对 Omicron 变异株的中和效力

Zang, Jinkai; Yin, Yannan; Xu, Shiqi; Qiao, Weihua; Liu, Qiuyue; Lavillette, Dimitri; Zhang, Chao; Wang, Haikun; Huang, Zhong

A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.

高亲和力 RBD 靶向纳米抗体可提高融合伙伴对抗 SARS-CoV-2 的效力

Yao Hebang, Cai Hongmin, Li Tingting, Zhou Bingjie, Qin Wenming, Lavillette Dimitri, Li Dianfan

The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles

SARS-CoV-2 的包膜蛋白和膜蛋白调节刺突蛋白的成熟和保留,从而使病毒样颗粒得以组装。

Boson, Bertrand; Legros, Vincent; Zhou, Bingjie; Siret, Eglantine; Mathieu, Cyrille; Cosset, François-Loïc; Lavillette, Dimitri; Denolly, Solène

Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines

三种原型毒株衍生重组蛋白疫苗诱导产生针对B.1.1.7、B.1.351和B.1.617.1 SARS-CoV-2变异株的广谱中和抗体

Yang, Yong; Zang, Jinkai; Xu, Shiqi; Zhang, Xueyang; Yuan, Sule; Wang, Haikun; Lavillette, Dimitri; Zhang, Chao; Huang, Zhong

Zika virus pathogenesis and current therapeutic advances

寨卡病毒的发病机制和目前的治疗进展

Mwaliko, Caroline; Nyaruaba, Raphael; Zhao, Lu; Atoni, Evans; Karungu, Samuel; Mwau, Matilu; Lavillette, Dimitri; Xia, Han; Yuan, Zhiming

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement

用SARS-CoV-2受体结合域进行免疫接种可诱导产生能够交叉中和SARS-CoV-2和SARS-CoV的抗体,且无需抗体依赖性增强作用。

Zang, Jinkai; Gu, Chenjian; Zhou, Bingjie; Zhang, Chao; Yang, Yong; Xu, Shiqi; Bai, Lulu; Zhang, Rong; Deng, Qiang; Yuan, Zhenghong; Tang, Hong; Qu, Di; Lavillette, Dimitri; Xie, Youhua; Huang, Zhong

A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein.

一种新型广谱中和抗体,靶向寨卡病毒包膜蛋白的聚糖环

Qu Panke, Zhang Chao, Li Min, Ma Weimin, Xiong Pei, Liu Qingwei, Zou Gang, Lavillette Dimitri, Yin Feifei, Jin Xia, Huang Zhong